David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Cambridge Quarterly of Healthcare Ethics 14 (1):47-56 (2005)
Over the past decade, genetic tests have become available for a wide variety of disorders. As a result we are able to predict, with some degree of certainty, whether or not an individual will develop such diseases as breast cancer, Huntington's disease, polycystic kidney disease, and familial adenomatous polyposis. The ability to predict disease poses several unique ethical considerations for clinical decisionmaking regarding the provision of genetic testing. Patients must be able to comprehend the complexities of genetic testing and the potential meaning of the results. Patients must consider the emotional, social, and economic consequences of revelations regarding their risk status. Also, obtaining information on risk status may have implications for persons other than the individual seeking genetic testing
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Loretta M. Kopelman (2007). Using the Best Interests Standard to Decide Whether to Test Children for Untreatable, Late-Onset Genetic Diseases. Journal of Medicine and Philosophy 32 (4):375 – 394.
Lainie Friedman Ross (2002). Predictive Genetic Testing for Conditions That Present in Childhood. Kennedy Institute of Ethics Journal 12 (3):225-244.
Cynthia B. Cohen (1998). Wrestling with the Future: Should We Test Children for Adult-Onset Genetic Conditions? Kennedy Institute of Ethics Journal 8 (2):111-130.
P. J. Malpas (2008). Predictive Genetic Testing of Children for Adult-Onset Diseases and Psychological Harm. Journal of Medical Ethics 34 (4):275-278.
Paula Boddington & Susan Hogben, Working Up Policy : The Use of Specific Disease Exemplars in Formulating General Principles Governing Childhood Genetic Testing. [REVIEW]
R. H. Dees & J. M. Kwon (2013). The Ethics of Krabbe Newborn Screening. Public Health Ethics 6 (1):114-128.
C. Mand, L. Gillam, M. B. Delatycki & R. E. Duncan (2012). Predictive Genetic Testing in Minors for Late-Onset Conditions: A Chronological and Analytical Review of the Ethical Arguments. Journal of Medical Ethics 38 (9):519-524.
J. Greenberg (1993). Huntington Disease: Prenatal Screening for Late Onset Disease. Journal of Medical Ethics 19 (2):121-121.
S. G. Post (1992). Huntington's Disease: Prenatal Screening for Late Onset Disease. Journal of Medical Ethics 18 (2):75-78.
Mariam Ghosn (2007). Predictive Testing for Huntington's Disease in Adolescents: Part 2. Chisholm Health Ethics Bulletin 12 (3):3.
Robert Samuel Wachbroit (1998). The Question Not Asked: The Challenge of Pleiotropic Genetic Tests. Kennedy Institute of Ethics Journal 8 (2):131-144.
Lee M. Silver (1990). New Reproductive Technologies in the Treatment of Human Infertility and Genetic Disease. Theoretical Medicine and Bioethics 11 (2).
Susan Lindee & Rebecca Mueller (2011). Is Cystic Fibrosis Genetic Medicine's Canary? Perspectives in Biology and Medicine 54 (3):316-331.
Lisa Bortolotti & Heather Widdows (2011). The Right Not to Know: The Case of Psychiatric Disorders. Journal of Medical Ethics 37 (11):673-676.
Added to index2010-08-24
Total downloads8 ( #187,474 of 1,413,409 )
Recent downloads (6 months)1 ( #154,345 of 1,413,409 )
How can I increase my downloads?